𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer

✍ Scribed by Carles Pericay Pijaume; Pilar Escudero Emperador; Román Bastús Piulats; Juan Manuel Campos Cervera; Gaspar Esquerdo Galiana; Manuel Gallén Castillo; Jordi Alfaro Gamero; Emma Dotor Navarro; Aleydis Pisa Gatell; Inmaculada Guasch Jordán; Eugeni Saigí Grau


Book ID
107597755
Publisher
Springer Milan
Year
2011
Tongue
Spanish
Weight
348 KB
Volume
13
Category
Article
ISSN
1699-048X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Cyclophosphamide, methotrexate, and chro
✍ Antoni Ribas; Joan Albanell; Luis-Alfonso Solé-Calvo; Enrique Gallardo; Joaquim 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Background: Chronic oral tegafur (a 5-fluorouracil prodrug) modulated by folinic acid has antitumor activity in patients with metastatic breast carcinoma resistant to 5-fluorouracil or doxorubicin-based regimens. in this study, bolus 5-fluorouracil was substituted with chronic oral tegafur and f